tizanidine hydrochloride

Product NDC
55700-259
11-digit product format
557000259
Labeler code
55700
Product ID
55700-259_300d99cf-3bc6-4da8-85aa-576f1b8c5bb3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tizanidine hydrochloride
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Labeler
Lake Erie Medical DBA Quality Care Products LLC
Application
NDA021447
Marketing category
NDA
Marketing start
2012-02-06
Marketing end
0000-00-00
Substance
TIZANIDINE HYDROCHLORIDE
Active strength
6 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
55700-259-302025-01-21C16284748780-1ba0f9c33-30bd-a910-e053-dadaa90a0b85685c018e-a822-471f-ad82-cf643c469840
55700-259-302021-01-29C16284748780-1ba0f9c33-30bd-a910-e053-dadaa90a0b85685c018e-a822-471f-ad82-cf643c469840

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
55700-259-30EA - Each55700-259094a1d8b-6677-497d-9279-18bde4bd411612018-01-12